期刊文献+

来氟米特和地塞米松对正常人外周血Th17和Th1细胞的免疫调节作用 被引量:1

Immunoregulatory effects of leflunomide and dexamethasone on Th17 and Th1 in human peripheral blood
下载PDF
导出
摘要 目的:探讨来氟米特活性代谢产物A771726和地塞米松对正常人外周血辅助性T细胞Th17和Th1细胞亚群的免疫调节作用。方法:体外分离正常健康人外周血CD4+T淋巴细胞,分别与不同剂量的A771726(15、30、60μg/ml)和地塞米松(10-6、10-7、10-8mol/L)体外共培养,采用流式细胞技术(FCM)检测Th17和Th1细胞亚群水平,采用实时荧光定量PCR技术检测IL-17、ROR-γt、IFN-γ以及T-bet的mRNA相对表达量。结果:A771726和地塞米松可以使Th1细胞亚群比例明显减少,且与药物浓度呈剂量依赖性。地塞米松可以抑制正常人外周血Th17细胞亚群在CD4+T淋巴细胞中的比例,且随着药物浓度的增加,抑制作用增强。而A771726对Th17细胞亚群则无抑制作用。结论:A771726可以抑制Th1细胞亚群,而对Th17细胞亚群无明显抑制作用,地塞米松可以使正常人外周血Th17和Th1细胞亚群减少。 Objective: To investigate the effect of A771726(activated metabolite of leflunomide) and dexamethasone on human peripheral blood Th17 and Th1 in vitro.Methods: The dexamethasone(10-6,10-7,10-8mol/L) and A771726(15,30,60 μg/ml) were added into wells containing CD4+T lymphocyes from donors.The percentage of Th17 and Th1 of CD4+ T cells were detected by the flow cytometry.The mRNA expression of IL-17,ROR-γt,IFN-γ and T-bet were measured respectively by RT-PCR.Results: The percentage of Th1 was decreased respectively by A771726 and dexamethasone,this effect was more obvious as increasing drug concentration.The percentage of Th17 was reduced by dexamethasone and positively related to drug concentration,but not related to A771726.Conclusion: A771726 could decrease the percentage of Th1 and had no effect on Th17.Dexamethasone could decrease percentage of Th1 and Th17 of CD4+ T cells.
出处 《江苏大学学报(医学版)》 CAS 2011年第6期503-506,共4页 Journal of Jiangsu University:Medicine Edition
基金 国家自然科学基金资助项目(30872335) 镇江市重点医学人才资助项目(2005009)
关键词 来氟米特 地塞米松 TH17 TH1 leflunomide dexamethasone Th17 Th1
  • 相关文献

参考文献10

  • 1Park H,Li Z,Yang XO,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin17[J].Nat Immunol,2005,6(11):1133-1141.
  • 2Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol,2005,6(11):1123-1132.
  • 3O′Donnell EF,Saili KS,Koch DC,et al.The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor[J].PLoS One,2010,5(10):e13128.
  • 4Damsker JM,Hansen AM,Caspi RR.Th1 and Th17 cells:adversaries and collaborators[J].Ann N Y Acad Sci,2010,1183:211-221.
  • 5Leipe J,Grunke M,Dechant C,et al.Role of Th17 cells in human autoimmune arthritis[J].Arthritis Rheum,2010,62(10):2876-2885.
  • 6Shah K,Lee WW,Lee SH,et al.Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus[J].Arthritis Res Ther,2010,12(2):R53.
  • 7Balanescu P,Balanescu E,Tanasescu C,et al.T helper 17 cell population in lupus erythematosus[J].Rom J Intern Med,2010,48(3):255-259.
  • 8Fukushima R,Kanamori S,Hirashiba M,et al.Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine[J].Toxicol Sci,2009,108(2):419-426.
  • 9Dimitrora P,Skapenko A,Schleyerbach R.Immunomodulatory functions of leflunomide:inhibition of Th1 cell activation and promotion of Th2 differentiation[J].Arthritis Rheum,2001,44(9 suppl):S216.
  • 10Liu X,Yang P,Lin X,et al.Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome[J].Clin Immunol,2009,131(2):333-342.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部